Table 3.
Definite probable stent thrombosis at 10 years in patients with and without diabetes mellitus
Event | PF-SES | DP-ZES | Hazard ratio | P |
---|---|---|---|---|
With diabetes | n = 575 | n = 295 | ||
Definite stent thrombosis | 7 (1.2) | 4 (1.5) | 0.89 (0.26–3.04) | 0.85 |
Probable stent thrombosis | 7 (1.2) | 3 (1.0) | 1.19 (0.31–4.60) | 0.80 |
Definite/probable stent thrombosis | 14 (2.5) | 7 (2.5) | 1.02 (0.41–2.52) | 0.97 |
Without diabetes | n = 1427 | n = 705 | ||
Definite stent thrombosis | 8 (0.6) | 3 (0.5) | 1.31 (0.35–4.92) | 0.69 |
Probable stent thrombosis | 7 (0.5) | 7 (1.1) | 0.49 (0.17–1.40) | 0.18 |
Definite/probable stent thrombosis | 15 (1.2) | 10 (1.6) | 0.74 (0.33–1.64) | 0.45 |
Data are shown as number (Kaplan–Meier estimates as percentages), hazard ratios are derived from Cox proportional hazard models, and P values are derived from Cox proportional hazard models. PF-SES indicates biodegradable polymer-free sirolimus- and probucol-eluting stent; DP-ZES indicates durable polymer zotarolimus-eluting stent